Other News To Note
Thursday, June 20, 2013
Amarin Corp. plc, of Dublin, Ireland, said the FDA will convene an advisory committee on Oct. 16 in connection with the agency's review of the supplemental new drug application seeking approval for the use of Vascepa (icosapent ethyl) capsules as an adjunct to diet in the treatment of adult patients with high triglycerides.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.